Literature DB >> 27465341

Bioinformatic analysis of non-VP1 capsid protein of coxsackievirus A6.

Hong-Bo Liu1, Guang-Fei Yang2, Si-Jia Liang3, Jun Lin4.   

Abstract

This study bioinformatically analyzed the non-VP1 capsid proteins (VP2-VP4) of Coxasckievirus A6 (CVA6), with an attempt to predict their basic physicochemical properties, structural/functional features and linear B cell eiptopes. The online tools SubLoc, TargetP and the others from ExPASy Bioinformatics Resource Portal, and SWISS-MODEL (an online protein structure modeling server), were utilized to analyze the amino acid (AA) sequences of VP2-VP4 proteins of CVA6. Our results showed that the VP proteins of CVA6 were all of hydrophilic nature, contained phosphorylation and glycosylation sites and harbored no signal peptide sequences and acetylation sites. Except VP3, the other proteins did not have transmembrane helix structure and nuclear localization signal sequences. Random coils were the major conformation of the secondary structure of the capsid proteins. Analysis of the linear B cell epitopes by employing Bepipred showed that the average antigenic indices (AI) of individual VP proteins were all greater than 0 and the average AI of VP4 was substantially higher than that of VP2 and VP3. The VP proteins all contained a number of potential B cell epitopes and some eiptopes were located at the internal side of the viral capsid or were buried. We successfully predicted the fundamental physicochemical properties, structural/functional features and the linear B cell eiptopes and found that different VP proteins share some common features and each has its unique attributes. These findings will help us understand the pathogenicity of CVA6 and develop related vaccines and immunodiagnostic reagents.

Entities:  

Keywords:  Coxsackievirus A6 (CVA6); bioinformatics; capsid proteins; linear B cell eiptopes; physicochemical properties; structural and functional domains

Mesh:

Substances:

Year:  2016        PMID: 27465341     DOI: 10.1007/s11596-016-1633-4

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  18 in total

1.  Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement.

Authors:  Sheng-Wen Huang; Ya-Fang Wang; Chun-Keung Yu; Ih-Jen Su; Jen-Ren Wang
Journal:  Virology       Date:  2011-11-09       Impact factor: 3.616

2.  Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification.

Authors:  M S Oberste; K Maher; D R Kilpatrick; M A Pallansch
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

Review 3.  An overview of bioinformatics tools for epitope prediction: implications on vaccine development.

Authors:  Ruth E Soria-Guerra; Ricardo Nieto-Gomez; Dania O Govea-Alonso; Sergio Rosales-Mendoza
Journal:  J Biomed Inform       Date:  2014-11-10       Impact factor: 6.317

4.  Three-dimensional structure of poliovirus at 2.9 A resolution.

Authors:  J M Hogle; M Chow; D J Filman
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

5.  A mechanism of immunoreceptor tyrosine-based activation motif (ITAM)-like sequences in the capsid protein VP2 in viral growth and pathogenesis of Coxsackievirus B3.

Authors:  Dae-Sun Kim; Jung-Hyun Park; Joo-Young Kim; Dokeun Kim; Jae-Hwan Nam
Journal:  Virus Genes       Date:  2011-10-26       Impact factor: 2.332

6.  An immunodominant N-terminal region of VP1 protein of poliovirion that is buried in crystal structure can be exposed in solution.

Authors:  M Roivainen; L Piirainen; T Rysä; A Närvänen; T Hovi
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

Review 7.  Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide.

Authors:  Lianlian Bian; Yiping Wang; Xin Yao; Qunying Mao; Miao Xu; Zhenglun Liang
Journal:  Expert Rev Anti Infect Ther       Date:  2015-06-25       Impact factor: 5.091

8.  Enterovirus 71 VP1 activates calmodulin-dependent protein kinase II and results in the rearrangement of vimentin in human astrocyte cells.

Authors:  Cong Haolong; Ning Du; Tian Hongchao; Yang Yang; Zhang Wei; Zhang Hua; Zhang Wenliang; Song Lei; Tien Po
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

9.  A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71.

Authors:  Longfa Xu; Delei He; Lisheng Yang; Zhiqun Li; Xiangzhong Ye; Hai Yu; Huan Zhao; Shuxuan Li; Lunzhi Yuan; Hongliu Qian; Yuqiong Que; James Wai Kuo Shih; Hua Zhu; Yimin Li; Tong Cheng; Ningshao Xia
Journal:  Sci Rep       Date:  2015-08-05       Impact factor: 4.379

10.  A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein.

Authors:  Tanja K Kiener; Qiang Jia; Tao Meng; Vincent Tak Kwong Chow; Jimmy Kwang
Journal:  PLoS Negl Trop Dis       Date:  2014-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.